Evidence map›Paper›PMID 27827829›Full record

ArticleBlood2017

Distinct signaling programs control human hematopoietic stem cell survival and proliferation.

David J H F Knapp, Colin A Hammond, Nima Aghaeepour, Paul H Miller, Davide Pellacani, Philip A Beer, Karen Sachs, Wenlian Qiao, WeiJia Wang, R Keith Humphries and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Regulation of Hematopoietic Stem Cell Fate and Malignancy.International journal of molecular sciences · 2020
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Loss of Function of DOCK4 in Myelodysplastic Syndromes Stem Cells is Restored by Inhibitors of DOCK4 Signaling Networks.Clinical cancer research : an official journal of the American Association for Cancer Research · 2019
    Article
  12. Article
  13. Single-cell analysis identifies a CD33Nature cell biology · 2018
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

David J H F KnappTerry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada.ORCID http://orcid.org/0000-0002-2161-9959
Colin A HammondTerry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada.
Nima AghaeepourBaxter Laboratory for Stem Cell Biology, Department of Microbiology & Immunology, Stanford University, Palo Alto, CA.
Paul H MillerTerry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada.
Davide PellacaniTerry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada.
Philip A BeerTerry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada.
Karen SachsBaxter Laboratory for Stem Cell Biology, Department of Microbiology & Immunology, Stanford University, Palo Alto, CA.
Wenlian QiaoTerrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada.
WeiJia WangTerrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada.
R Keith HumphriesTerry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada.
Guy SauvageauMolecular Genetics of Stem Cells Laboratory, Institute of Research in Immunology and Cancer, University of Montreal, Montreal, QC, Canada.
Peter W ZandstraTerrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada.
Sean C BendallDepartment of Pathology, Stanford University, Palo Alto, CA; and.
Garry P NolanBaxter Laboratory for Stem Cell Biology, Department of Microbiology & Immunology, Stanford University, Palo Alto, CA.
Carl HansenCentre for High-Throughput Biology, University of British Columbia, Vancouver, BC, Canada.
Connie J EavesTerry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada.
BC Cancer Agency · CAStanford University · USUniversity of Toronto · CAInstitute for Research in Immunology and Cancer · CAPalo Alto University · USUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several growth factors (GFs) that together promote quiescent human hematopoietic stem cell (HSC) expansion ex vivo have been identified; however, the molecular mechanisms by which these GFs regulate the survival, proliferation. and differentiation of human HSCs remain poorly understood. We now describe experiments in which we used mass cytometry to simultaneously measure multiple surface markers, transcription factors, active signaling intermediates, viability, and cell-cycle indicators in single CD34

Indexed as

AnimalsCell ProliferationCell SurvivalHematopoietic Stem CellsHumansImmunophenotypingIntercellular Signaling Peptides and ProteinsMiceSignal TransductionTranscription FactorsIntercellular Signaling Peptides and ProteinsTranscription Factors

Identifiers

PMID27827829
PMCPMC5271174
OpenAlexW2553864385

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.